A Perino

ORCID: 0000-0003-3929-5179
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Uterine Myomas and Treatments
  • Endometriosis Research and Treatment
  • Cervical Cancer and HPV Research
  • Gynecological conditions and treatments
  • Reproductive System and Pregnancy
  • Reproductive Biology and Fertility
  • Hepatitis B Virus Studies
  • Endometrial and Cervical Cancer Treatments
  • Genital Health and Disease
  • Assisted Reproductive Technology and Twin Pregnancy
  • Ovarian function and disorders
  • Reproductive Health and Technologies
  • Sperm and Testicular Function
  • Ovarian cancer diagnosis and treatment
  • Ectopic Pregnancy Diagnosis and Management
  • Prenatal Screening and Diagnostics
  • Blood groups and transfusion
  • Urological Disorders and Treatments
  • Pelvic floor disorders treatments
  • Animal Virus Infections Studies
  • Urinary and Genital Oncology Studies
  • Pregnancy and preeclampsia studies
  • Hormonal and reproductive studies
  • Pregnancy-related medical research
  • Sexual Differentiation and Disorders

Ospedale Vincenzo Cervello
2015-2025

University of Palermo
2016-2025

Azienda di Rilievo Nazionale ed Alta Specializzazione
2022

Ministero della Salute
2016

Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo
2008-2015

Bocconi University
2015

Polyclinic General Hospital
2015

Centro Laser
2014

University of Messina
2012

Federación Colombiana de Obstetricia y Ginecología
2006

Abstract Objective To compare the 2 most efficacious therapeutic regimens, intravenous immunoglobulin (IVIG) and anticoagulation with low molecular weight (LMW) heparin plus low‐dose aspirin, in women recurrent pregnancy loss associated antiphospholipid antibodies (aPL). Methods We examined 40 abortion (at least 3 occurrences) repeatedly positive test results for anticardiolipin or lupus anticoagulant. The subjects were randomly assigned to treatment IVIG LMW aspirin. Both therapies started...

10.1002/art.10957 article EN Arthritis & Rheumatism 2003-02-28

To develop a prenatal ultrasound staging system for placenta accreta spectrum (PAS) disorders in women with previa and to evaluate its association surgical outcome, placental invasion the clinical PAS proposed by International Federation of Gynecology Obstetrics (FIGO).This was secondary retrospective analysis prospectively collected data from previa. We classified according following disorders, based upon presence signs previa: PAS0, no or lacunae but evidence abnormal uterus-bladder...

10.1002/uog.20246 article EN Ultrasound in Obstetrics and Gynecology 2019-03-05

BACKGROUND: In ∼12–14% of young normogonadotrophic women treated with a depot GnRH agonist long protocol, the initial ovarian response to recombinant human FSH (rFSH) can be suboptimal. We have tested hypothesis that these may benefit from LH (rLH) supplementation in multicentre, prospective, randomized trial compared patients an rFSH step-up protocol. METHODS: A total 260 undergoing controlled stimulation protocol for IVF/ICSI were enrolled. The starting dose was 225 IU. One hundred and...

10.1093/humrep/deh625 article EN Human Reproduction 2004-12-02

The present randomized study was undertaken in order to compare the short-term results between total laparoscopic hysterectomy and abdominal a centre with experience surgery. From January 1997 September 1998 inclusive, 102 women aged 44–71 years were randomly assigned either (n = 51 patients) or patients). patients' demographic characteristics similar both groups. Average intra-operative blood loss lower than (P ≤ 0.001). average time employed for 104.1 ± 26.98 min; according learning curve...

10.1093/humrep/14.12.2996 article EN Human Reproduction 1999-12-01

A prospective study was performed to assess the relationship between human papillomavirus (HPV) infection in 199 infertile couples and outcome of assisted reproductive technologies (ARTs). highly statistically significant correlation pregnancy loss rate (proportion pregnancies detected by β-hCG that did not progress beyond 20 weeks) positive HPV DNA testing male partner couples, compared with negatives, observed (66.7% vs. 15%).

10.1016/j.fertnstert.2010.11.047 article EN publisher-specific-oa Fertility and Sterility 2010-12-18

Several studies have shown higher pregnancy rates and better perinatal outcomes with frozen embryo transfers than fresh techniques, results in patients polycystic ovary syndrome (PCOS) but a rate of complications such as preeclampsia. This retrospective cohort study aims to compare the cumulative live birth rates, maternal neonatal (ET) frozen-embryo (FET) infertile women who underwent assisted reproduction techniques (ART) at Azienda Ospedaliera Ospedali Riuniti (AOOR) Villa Sofia Cervello,...

10.26355/eurrev_202307_33152 article EN PubMed 2023-07-01

To evaluate the efficacy of dienogest + estradiol valerate (E2V) and gonadotrophin-releasing hormone analogue (GnRH-a) in reducing recurrence pain patients with chronic pelvic due to laparoscopically diagnosed treated endometriosis.Multi-center, prospective, randomized study.Three university departments obstetrics gynecology Italy.Seventy-eight women who underwent laparoscopic surgery for endometriosis combined pain.Post-operative administration E2V 9 months (group 1) or GnRH-a monthly 6...

10.1111/aogs.12633 article EN Acta Obstetricia Et Gynecologica Scandinavica 2015-03-10

In Italy, the cohorts of women who were offered Human papillomavirus (HPV) vaccination in 2007/08 will reach age (25 years) for cervical cancer (CC) screening from 2017. The simultaneous shift cytology-based to HPV test-based gives opportunity unprecedented reorganisation CC prevention. ONS (National Screening Monitoring Centre) Directive and GISCi (Italian Group Cervical Screening) identified consensus conference as most suitable method addressing this topic. A summary recommendations is...

10.1016/j.ypmed.2016.11.020 article EN cc-by-nc-nd Preventive Medicine 2016-11-25
Coming Soon ...